OA08672A - Cephalosporin salts and injectable compositions. - Google Patents
Cephalosporin salts and injectable compositions.Info
- Publication number
- OA08672A OA08672A OA58918A OA58918A OA08672A OA 08672 A OA08672 A OA 08672A OA 58918 A OA58918 A OA 58918A OA 58918 A OA58918 A OA 58918A OA 08672 A OA08672 A OA 08672A
- Authority
- OA
- OAPI
- Prior art keywords
- injectable compositions
- cephalosporin salts
- cephalosporin
- salts
- injectable
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
- A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
- C07D501/14—Compounds having a nitrogen atom directly attached in position 7
- C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
- C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
- C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
- C07D501/38—Methylene radicals, substituted by nitrogen atoms; Lactams thereof with the 2-carboxyl group; Methylene radicals substituted by nitrogen-containing hetero rings attached by the ring nitrogen atom; Quaternary compounds thereof
- C07D501/46—Methylene radicals, substituted by nitrogen atoms; Lactams thereof with the 2-carboxyl group; Methylene radicals substituted by nitrogen-containing hetero rings attached by the ring nitrogen atom; Quaternary compounds thereof with the 7-amino radical acylated by carboxylic acids containing hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Oncology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Cephalosporin Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US76223585A | 1985-08-05 | 1985-08-05 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| OA08672A true OA08672A (en) | 1989-03-31 |
Family
ID=25064475
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| OA58918A OA08672A (en) | 1985-08-05 | 1986-08-05 | Cephalosporin salts and injectable compositions. |
Country Status (34)
| Country | Link |
|---|---|
| JP (1) | JPH0615548B2 (fr) |
| KR (1) | KR930003121B1 (fr) |
| AR (1) | AR243894A1 (fr) |
| AT (1) | AT390957B (fr) |
| AU (1) | AU597262B2 (fr) |
| BE (1) | BE905219A (fr) |
| CA (1) | CA1284994C (fr) |
| CH (1) | CH675581A5 (fr) |
| CS (2) | CS276849B6 (fr) |
| CY (1) | CY1614A (fr) |
| DD (2) | DD254941A5 (fr) |
| DE (1) | DE3626375A1 (fr) |
| DK (1) | DK162053C (fr) |
| EG (1) | EG18003A (fr) |
| ES (1) | ES2002112A6 (fr) |
| FI (1) | FI84484C (fr) |
| FR (1) | FR2585705B1 (fr) |
| GB (1) | GB2179936B (fr) |
| GR (1) | GR862055B (fr) |
| HK (1) | HK99691A (fr) |
| HU (1) | HU196602B (fr) |
| IE (1) | IE59222B1 (fr) |
| IL (1) | IL79608A (fr) |
| IT (1) | IT1197067B (fr) |
| LU (2) | LU86540A1 (fr) |
| MY (1) | MY102212A (fr) |
| NL (1) | NL8601991A (fr) |
| OA (1) | OA08672A (fr) |
| PT (1) | PT83134B (fr) |
| SE (1) | SE469633B (fr) |
| SG (1) | SG79791G (fr) |
| SU (1) | SU1516013A3 (fr) |
| YU (1) | YU45793B (fr) |
| ZA (1) | ZA865842B (fr) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1988010263A1 (fr) * | 1987-06-25 | 1988-12-29 | Banyu Pharmaceutical Co., Ltd. | Composes cristallins de cephalosporine, procede de preparation et produits intermediaires pour la preparation de ces composes |
| US4959469A (en) * | 1984-12-27 | 1990-09-25 | Banyu Pharmaceutical Company, Ltd. | Crystalline cephalosporin compounds |
| US4883868A (en) * | 1984-12-27 | 1989-11-28 | Banyu Pharmaceutical Co., Ltd. | 7-amino-3-(substituted isoindolinium)methyl-3-cephem derivatives |
| US5244891A (en) * | 1985-08-05 | 1993-09-14 | Bristol-Myers Squibb Company | Injectable compositions of cefepime dihydrochloride hydrate |
| US4910301A (en) * | 1985-08-05 | 1990-03-20 | Bristol-Myers Company | Cefepime cephalosporin salts |
| US4808617A (en) * | 1985-12-18 | 1989-02-28 | Bristol-Myers Company | Lyophilized or precipitated cephalosporin zwitterion and salt combination |
| JPH02101081A (ja) * | 1988-10-08 | 1990-04-12 | Meiji Seika Kaisha Ltd | セファロスポリン誘導体結晶性二塩酸塩及びその製造法 |
| CA2011116C (fr) * | 1989-03-06 | 1999-11-16 | Murray A. Kaplan | Dihydrochlorure de bmy-28142 lyophilise pour usage parenteral |
| CA2101571A1 (fr) * | 1992-09-08 | 1994-03-09 | Elizabeth A. Garofalo | Dihydrate cristallise d'un sel de cephalosporine dihydrate; compositions injectables a base de ce compose |
| EP0638573A1 (fr) * | 1993-08-10 | 1995-02-15 | Lucky Ltd. | Hydrates crystallins d'une céphalosporine et procédé pour leur préparation |
| CN100543027C (zh) | 2003-12-23 | 2009-09-23 | 桑多斯有限公司 | 制备用于合成头孢菌素的中间体的方法 |
| WO2008056221A2 (fr) * | 2006-11-06 | 2008-05-15 | Orchid Chemicals & Pharmaceuticals Limited | Sel de sulfate cristallin d'antibiotique céphalosporine |
| DE102012101680A1 (de) * | 2012-02-29 | 2013-08-29 | Aicuris Gmbh & Co. Kg | Pharmazeutische Zubereitung enthaltend ein antiviral wirksames Dihydrochinazolinderivat |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS55151588A (en) * | 1979-05-14 | 1980-11-26 | Takeda Chem Ind Ltd | Preparation of cephalosporin salt crystal |
| US4406899A (en) * | 1982-03-04 | 1983-09-27 | Bristol-Myers Company | Cephalosporins |
| CA1213882A (fr) * | 1982-03-04 | 1986-11-12 | Jun Okumura | Cephalosporines |
| US4525473A (en) * | 1983-03-30 | 1985-06-25 | Bristol-Myers Company | Cephalosporins |
| DE3419015A1 (de) * | 1984-05-22 | 1985-11-28 | Bayer Ag, 5090 Leverkusen | Verfahren zur herstellung von cephalosporinen |
| GB8424692D0 (en) * | 1984-10-01 | 1984-11-07 | Glaxo Group Ltd | Chemical compounds |
| GB2165245B (en) * | 1984-10-01 | 1988-05-25 | Glaxo Group Ltd | Chemical compounds |
-
1986
- 1986-07-28 CA CA000514766A patent/CA1284994C/fr not_active Expired - Lifetime
- 1986-07-28 FR FR8610892A patent/FR2585705B1/fr not_active Expired
- 1986-07-29 AR AR86304717A patent/AR243894A1/es active
- 1986-07-30 AU AU60694/86A patent/AU597262B2/en not_active Expired
- 1986-07-31 YU YU137186A patent/YU45793B/sh unknown
- 1986-08-01 IE IE207886A patent/IE59222B1/en not_active IP Right Cessation
- 1986-08-01 FI FI863155A patent/FI84484C/fi not_active IP Right Cessation
- 1986-08-04 CS CS903570A patent/CS276849B6/cs unknown
- 1986-08-04 IL IL79608A patent/IL79608A/xx not_active IP Right Cessation
- 1986-08-04 IT IT21409/86A patent/IT1197067B/it active Protection Beyond IP Right Term
- 1986-08-04 SE SE8603308A patent/SE469633B/sv not_active IP Right Cessation
- 1986-08-04 CH CH3117/86A patent/CH675581A5/de not_active IP Right Cessation
- 1986-08-04 GR GR862055A patent/GR862055B/el unknown
- 1986-08-04 DK DK371886A patent/DK162053C/da not_active IP Right Cessation
- 1986-08-04 BE BE07217010A patent/BE905219A/fr not_active IP Right Cessation
- 1986-08-04 CS CS865827A patent/CS276717B6/cs unknown
- 1986-08-04 LU LU86540A patent/LU86540A1/fr unknown
- 1986-08-04 PT PT83134A patent/PT83134B/pt unknown
- 1986-08-04 NL NL8601991A patent/NL8601991A/nl not_active Application Discontinuation
- 1986-08-04 DE DE19863626375 patent/DE3626375A1/de not_active Ceased
- 1986-08-04 GB GB8618989A patent/GB2179936B/en not_active Expired
- 1986-08-04 ZA ZA865842A patent/ZA865842B/xx unknown
- 1986-08-04 LU LU88574C patent/LU88574I2/fr unknown
- 1986-08-04 JP JP61183288A patent/JPH0615548B2/ja not_active Expired - Lifetime
- 1986-08-04 SU SU864027914A patent/SU1516013A3/ru active
- 1986-08-05 HU HU863376A patent/HU196602B/hu unknown
- 1986-08-05 AT AT0211086A patent/AT390957B/de not_active IP Right Cessation
- 1986-08-05 OA OA58918A patent/OA08672A/xx unknown
- 1986-08-05 KR KR1019860006445A patent/KR930003121B1/ko not_active IP Right Cessation
- 1986-08-05 DD DD86293433A patent/DD254941A5/de unknown
- 1986-08-05 ES ES8600872A patent/ES2002112A6/es not_active Expired
-
1987
- 1987-09-29 MY MYPI87002279A patent/MY102212A/en unknown
-
1988
- 1988-03-30 DD DD88314213A patent/DD268395A5/de unknown
-
1989
- 1989-08-04 EG EG489/86A patent/EG18003A/xx active
-
1991
- 1991-10-02 SG SG797/91A patent/SG79791G/en unknown
- 1991-12-05 HK HK996/91A patent/HK99691A/xx not_active IP Right Cessation
-
1992
- 1992-07-10 CY CY1614A patent/CY1614A/xx unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB8602591D0 (en) | Aqueous polyurethane-polyolefin composition | |
| OA08347A (en) | Gazoline composition. | |
| GB8523849D0 (en) | Rangefinders | |
| CY1663A (en) | Cephalosporin salts and injectable compositions | |
| EP0186187A3 (en) | Cephalosporin derivatives | |
| NZ215333A (en) | Cephem compounds and pharmaceutical compositions | |
| GB8519452D0 (en) | Injectable solutions | |
| OA08672A (en) | Cephalosporin salts and injectable compositions. | |
| EP0182210A3 (en) | Cephalosporin derivatives | |
| NZ215717A (en) | Cephalosporin derivatives | |
| ZA862634B (en) | Substituted thiazolidinones | |
| NZ214048A (en) | Cephalosporins and pharmaceutical compositions | |
| GB8512634D0 (en) | Additive | |
| EP0181940A4 (fr) | Derives de cephalosporine. | |
| NZ210761A (en) | Cephalosporin derivatives and pharmaceutical compositions | |
| IL88959A (en) | Cephalosporin salts and injectable compositions | |
| PH21201A (en) | Cephalosporin derivatives and salts thereof | |
| NZ216624A (en) | Cephalosporins and pharmaceutical compositions | |
| DE3573920D1 (en) | Cephalosporin derivatives | |
| IE841527L (en) | Cephalosporin salts | |
| HUT44607A (en) | Emulsifyer-anti-corrosive additive composition | |
| IE850448L (en) | Cephalosporin derivatives | |
| ZA862347B (en) | Cephalosporin derivatives | |
| IL79200A0 (en) | Cephalosporin derivatives | |
| IL78351A0 (en) | Cephalosporin derivatives |